These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 1622111)
1. Immunohistochemistry, in situ hybridization and polymerase chain reaction (PCR) in detecting c-myc expression in human malignancies. Tervahauta AI; Syrjänen SM; Kallio PJ; Syrjänen KJ Anticancer Res; 1992; 12(3):1005-11. PubMed ID: 1622111 [TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas. Walker RA; Senior PV; Jones JL; Critchley DR; Varley JM J Pathol; 1989 Jun; 158(2):97-105. PubMed ID: 2569035 [TBL] [Abstract][Full Text] [Related]
3. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction. Naidu R; Wahab NA; Yadav M; Kutty MK Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932 [TBL] [Abstract][Full Text] [Related]
4. Amplification of the N-myc oncogene in an adenocarcinoma cell line of the lung. Kashii T; Mizushima Y; Nakagawa K; Monno S; Yano S Anticancer Res; 1992; 12(3):621-4. PubMed ID: 1622116 [TBL] [Abstract][Full Text] [Related]
5. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes. Pechoux C; Chardonnet Y; Chignol MC; Noël P Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818 [TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis]. Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638 [TBL] [Abstract][Full Text] [Related]
7. [Correlation between malignancy of gastric cancer and c-myc DNA amplification or overexpression of c-myc protein]. Nakata B; Onoda N; Chung YS; Maeda K; Nishimura S; Yashiro M; Nitta A; Kubo T; Kato Y; Sowa M Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():176-9. PubMed ID: 7611785 [TBL] [Abstract][Full Text] [Related]
8. [Detection of c-myc translocation in human lung cancer cells by fluorescence in situ hybridization (FISH)]. Lu Y; Cheng S; Guo S Zhonghua Yi Xue Za Zhi; 1995 Apr; 75(4):214-5, 255. PubMed ID: 7788551 [TBL] [Abstract][Full Text] [Related]
9. In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast. Mariani-Costantini R; Escot C; Theillet C; Gentile A; Merlo G; Lidereau R; Callahan R Cancer Res; 1988 Jan; 48(1):199-205. PubMed ID: 2825967 [TBL] [Abstract][Full Text] [Related]
10. Study of the expression of the gene encoding Ki-67 antigen in human pancreatic cancer using non-radioactive in situ hybridization and immunohistochemistry. Wu Y; Peng S; Sheng H Chin Med J (Engl); 1997 Nov; 110(11):869-74. PubMed ID: 9772421 [TBL] [Abstract][Full Text] [Related]
11. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas. Robanus-Maandag EC; Bosch CA; Kristel PM; Hart AA; Faneyte IF; Nederlof PM; Peterse JL; van de Vijver MJ J Pathol; 2003 Sep; 201(1):75-82. PubMed ID: 12950019 [TBL] [Abstract][Full Text] [Related]
12. Evidence by in situ hybridization that c-erbB-2 proto-oncogene expression is a marker of malignancy and is expressed in lung adenocarcinomas. Pääkkö P; Nuorva K; Kamel D; Soini Y Am J Respir Cell Mol Biol; 1992 Sep; 7(3):325-34. PubMed ID: 1355655 [TBL] [Abstract][Full Text] [Related]
13. Demonstration of constant upregulation of the telomerase RNA component in human gastric carcinomas using in situ hybridization. Heine B; Hummel M; Demel G; Stein H J Pathol; 1998 Jun; 185(2):139-44. PubMed ID: 9713339 [TBL] [Abstract][Full Text] [Related]
15. c-MYC mRNA is present in human sperm cells. Kumar G; Patel D; Naz RK Cell Mol Biol Res; 1993; 39(2):111-7. PubMed ID: 8220581 [TBL] [Abstract][Full Text] [Related]
16. Real-time reverse transcription-PCR and fluorescence in-situ hybridization are complementary to understand the mechanisms involved in HER-2/neu overexpression in human breast carcinomas. Vanden Bempt I; Vanhentenrijk V; Drijkoningen M; Wlodarska I; Vandenberghe P; De Wolf-Peeters C Histopathology; 2005 Apr; 46(4):431-41. PubMed ID: 15810955 [TBL] [Abstract][Full Text] [Related]
17. [Amplification of the expression of the c-myc oncogene in bronchial epidermoid carcinoma in man]. Douc-Rasy S; Terrier P; Kemeny JL; Amouroux J; Riou G C R Acad Sci III; 1985; 301(13):621-6. PubMed ID: 3937573 [TBL] [Abstract][Full Text] [Related]
18. Analysis of c-myc oncogene in human esophageal carcinoma: immunohistochemistry, in situ hybridization and northern and Southern blot studies. Miyazaki S; Sasno H; Shiga K; Sawai T; Nishihira T; Okamoto H; Mori S Anticancer Res; 1992; 12(5):1747-55. PubMed ID: 1444241 [TBL] [Abstract][Full Text] [Related]
19. A study of myc-related gene expression in small cell lung cancer by in situ hybridization. Gu J; Linnoila RI; Seibel NL; Gazdar AF; Minna JD; Brooks BJ; Hollis GF; Kirsch IR Am J Pathol; 1988 Jul; 132(1):13-7. PubMed ID: 2456019 [TBL] [Abstract][Full Text] [Related]
20. Oncogene amplification detected by in situ hybridization in radiation-induced skin cancers in rats. Jin Y; Burns FJ; Garte SJ Radiat Res; 1992 Nov; 132(2):193-9. PubMed ID: 1438701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]